MedPath

LearningRx Cognitive Training for TBI

Not Applicable
Conditions
Traumatic Brain Injury (TBI)
Interventions
Behavioral: LearningRx cognitive training
Registration Number
NCT02918994
Lead Sponsor
Gibson Institute of Cognitive Research
Brief Summary

The purpose of this investigation is to conduct a series of case studies on the impact of LearningRx cognitive training on cognitive skills, brain structure, and daily functioning for participants with Traumatic Brain Injury (TBI).

Detailed Description

Using a multiple baseline design across cases with start point randomization, the proposed study will examine the outcomes from LearningRx one-on-one cognitive training across domains on standardized measures used to monitor treatment effectiveness for TBI.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Age 18+ previously diagnosed with TBI
  • Living in the greater Colorado Springs area
Exclusion Criteria
  • No braces, metal implants, or claustrophobia that would contraindicate magnetic resonance imaging

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
LearningRx cognitive trainingLearningRx cognitive trainingThe intervention is a 60-hour, clinician-delivered cognitive training program.
Primary Outcome Measures
NameTimeMethod
Evidence of overall cognitive function improvementwithin 14 days after completing the intervention

Confirmed by change in pretest to post-test scores on the Woodcock Johnson IV - Tests of Cognitive Abilities

Secondary Outcome Measures
NameTimeMethod
Evidence of reduction in TBI symptomswithin 14 days after completing the intervention

As confirmed by pretest to post-test changes on the Traumatic Brain Injury Checklist

Evidence of change in brain structurewithin 30 days after completing the intervention

Confirmed by change in pretest to post-test neuroimaging using MRI

Evidence of change in brain activitywithin 30 days after completing the intervention

As confirmed by pretest to post-test changes in electrical activity measured by qEEG

Evidence of improvement in visual attentionwith 14 days after completing the intervention

Confirmed by change in pretest to post-test scores on the Conners Continous Performance Test (CPT-3)

Evidence of improvement in auditory attentionwith 14 days after completing the intervention

Confirmed by change in pretest to post-test scores on the Auditory Attention Test (CATA)

Trial Locations

Locations (1)

Gibson Institute of Cognitive Research

🇺🇸

Colorado Springs, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath